Prognostic indicators for survival after resection of pancreatic adenocarcinoma*

https://doi.org/10.1016/S0002-9610(05)80406-4Get rights and content

From October 1983 to October 1990, 799 patients with the diagnosis of pancreatic adenocarcinoma were admitted to Memorial Sloan-Kettering Cancer Center, and their records were entered into a prospective database. Curative resection was possible in 146 patients (18%), with a 30-day operative mortality of 3.4%. Median follow-up of survivors in the resection group was 28 months. Actuarial 5-year survival in patients who did not undergo resection was 0% (n=653), compared with 24% in the patients who had resection (p < 0.00001). Of 52 patients available for 5-year follow-up, 10 (19%) were alive at 5 years. Tumors with lymph node involvement, poor histologic tumor differentiation, and tumor size greater than 2.5 cm were predictors of a significantly worse survival in both univariate and multivariate analysis. Other factors, including blood transfusion, blood loss, and operative time, had no significant effect on survival. The majority of patients with pancreatic adenocarcinoma have unresectable disease with a poor prognosis. For patients who undergo curative resection, their prognosis appears to be determined by the biology of the tumor rather than factors involved in the resection.

References (15)

There are more references available in the full text version of this article.

Cited by (767)

  • Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon

    2022, Hematology/Oncology Clinics of North America
    Citation Excerpt :

    Surgery remains the mainstay of curative intent treatment with complete resection being the goal.4,5 However, approximately 80% of patients are initially either inoperable or borderline operable due to the proximity and involvement of vessels or other critical organs.6 The most common first site of failure after definitive surgery is distant; however, a significant proportion of patients will progress locally with some studies reporting a local failure rate as high as 50% in resected PDAC.7

View all citing articles on Scopus
*

Presented at the 33rd Annual Meeting of the Society for Surgery of the Alimentary Tract, San Francisco, California May 11–13, 1992.

1

From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. Supported in part by the Milton and Bernice Stern Foundation.

View full text